Varta
← Back to stories

From The Hindu BusinessLine

Center-Right Owned by The Hindu Group (Kasturi & Sons)

Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr

Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr

What each side is saying

One outlet's own words from each side of the spectrum. Quoted, not summarised.

  • right · 2 outlets

    Aurobindo Pharma's revenue rose 24% to Rs 10,263 crore, compared to Rs 8,286 crore in the year-ago period.

    — NDTV

RSS excerpt

The total revenue of the Hyderabad-based company grew 24 per cent

Coverage arrived over 0 hours — first from NDTV, latest from The Hindu BusinessLine.

✓ Corroborated Coverage 2 news outlets reporting

Fact-Check & Bias Analysis

Reported by multiple independent newsrooms.

Coverage Bias Distribution

Based on 2 reporting publishers
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 2 (100%)

Compare all reporting outlets (2)

Read more news

See all latest stories →